Suppr超能文献

人类免疫缺陷病毒相关的微生物易位与丙型肝炎的进展

Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.

作者信息

Balagopal Ashwin, Philp Frances H, Astemborski Jacquie, Block Timothy M, Mehta Anand, Long Ronald, Kirk Gregory D, Mehta Shruti H, Cox Andrea L, Thomas David L, Ray Stuart C

机构信息

Division of Infectious Diseases, Viral Hepatitis Center, Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.

出版信息

Gastroenterology. 2008 Jul;135(1):226-33. doi: 10.1053/j.gastro.2008.03.022. Epub 2008 Mar 29.

Abstract

BACKGROUND & AIMS: Human immunodeficiency virus (HIV)-1 infection has been associated with enhanced microbial translocation, and microbial translocation is a mechanism through which alcohol and some enteric conditions cause liver disease. We hypothesized that HIV promotes liver disease by enhancing microbial translocation.

METHODS

We studied human cohorts in which hepatitis C virus (HCV) and HIV outcomes were carefully characterized.

RESULTS

HIV-related CD4(+) lymphocyte depletion was strongly associated with microbial translocation as indicated by elevated levels of circulating lipopolysaccharide (LPS), LPS-binding protein, soluble CD14, and fucose-binding lectin (AAL) reactive to immunoglobulin G specific for the alpha-galactose epitope and suppressed levels of endotoxin core antibodies (EndoCAb IgM) in HIV-infected subjects compared with the same persons before they had HIV infection and compared with HIV-uninfected subjects. The same measures of microbial translocation were strongly associated with HCV-related liver disease progression (cirrhosis), eg, LPS, odds ratio, 19.0 (P = .002); AAL, odds ratio, 27.8 (P < .0001); in addition, levels of LPS were elevated prior to recognition of cirrhosis.

CONCLUSIONS

Microbial translocation may be a fundamental mechanism through which HIV accelerates progression of chronic liver disease.

摘要

背景与目的

人类免疫缺陷病毒1型(HIV-1)感染与微生物易位增强有关,而微生物易位是酒精和某些肠道疾病导致肝病的一种机制。我们推测HIV通过增强微生物易位促进肝病发生。

方法

我们研究了仔细界定了丙型肝炎病毒(HCV)和HIV结局的人类队列。

结果

与感染HIV之前的同一人群以及未感染HIV的受试者相比,HIV相关的CD4(+)淋巴细胞耗竭与微生物易位密切相关,这表现为HIV感染受试者循环脂多糖(LPS)、LPS结合蛋白、可溶性CD14以及对α-半乳糖表位特异性免疫球蛋白G有反应的岩藻糖结合凝集素(AAL)水平升高,以及内毒素核心抗体(EndoCAb IgM)水平降低。微生物易位的相同指标与HCV相关的肝病进展(肝硬化)密切相关,例如,LPS的比值比为19.0(P = .002);AAL的比值比为27.8(P < .0001);此外,在诊断出肝硬化之前LPS水平就已升高。

结论

微生物易位可能是HIV加速慢性肝病进展的一种基本机制。

相似文献

1
Human immunodeficiency virus-related microbial translocation and progression of hepatitis C.
Gastroenterology. 2008 Jul;135(1):226-33. doi: 10.1053/j.gastro.2008.03.022. Epub 2008 Mar 29.
2
Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.
J Infect Dis. 2013 Aug 15;208(4):679-89. doi: 10.1093/infdis/jit225. Epub 2013 May 17.
3
Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection.
Gastroenterology. 2011 Oct;141(4):1220-30, 1230.e1-3. doi: 10.1053/j.gastro.2011.06.063. Epub 2011 Jul 2.
4
Systemic immune activation and microbial translocation in dual HIV/tuberculosis-infected subjects.
J Infect Dis. 2013 Jun 15;207(12):1841-9. doi: 10.1093/infdis/jit092. Epub 2013 Mar 11.
5
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.
Dig Liver Dis. 2015 Mar;47(3):218-25. doi: 10.1016/j.dld.2014.11.012. Epub 2014 Nov 29.
6
Comparative evaluation of microbial translocation products (LPS, sCD14, IgM Endocab) in HIV-1 infected Indian individuals.
Microb Pathog. 2017 Oct;111:331-337. doi: 10.1016/j.micpath.2017.08.004. Epub 2017 Aug 9.
7
Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections.
J Infect Dis. 2010 Apr 15;201(8):1150-4. doi: 10.1086/651430.

引用本文的文献

1
Gut microbiota dysbiosis in people living with HIV who have cancer: novel insights and diagnostic potential.
Front Immunol. 2025 Aug 25;16:1598650. doi: 10.3389/fimmu.2025.1598650. eCollection 2025.
3
Metabolic dysfunction-associated steatotic liver disease in people with HIV.
Curr Opin HIV AIDS. 2025 Jul 1;20(4):350-358. doi: 10.1097/COH.0000000000000952. Epub 2025 May 21.
5
HIV, the gut microbiome and clinical outcomes, a systematic review.
PLoS One. 2024 Dec 9;19(12):e0308859. doi: 10.1371/journal.pone.0308859. eCollection 2024.
6
Microbiota, natural products, and human health: exploring interactions for therapeutic insights.
Front Cell Infect Microbiol. 2024 Jul 5;14:1371312. doi: 10.3389/fcimb.2024.1371312. eCollection 2024.
7
Effects of Food Insecurity on Hepatic Steatosis and Fibrosis in People With HIV.
Clin Gastroenterol Hepatol. 2024 Jul;22(7):1427-1435.e6. doi: 10.1016/j.cgh.2024.03.017. Epub 2024 Apr 5.
8
A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease.
Front Immunol. 2023 Dec 14;14:1297378. doi: 10.3389/fimmu.2023.1297378. eCollection 2023.
10
The human microbiome and gut-liver axis in people living with HIV.
Curr HIV/AIDS Rep. 2023 Jun;20(3):170-180. doi: 10.1007/s11904-023-00657-x. Epub 2023 May 2.

本文引用的文献

2
The liver in celiac disease.
Hepatology. 2007 Nov;46(5):1650-8. doi: 10.1002/hep.21949.
3
TLR4 enhances TGF-beta signaling and hepatic fibrosis.
Nat Med. 2007 Nov;13(11):1324-32. doi: 10.1038/nm1663. Epub 2007 Oct 21.
5
Structural biology of the LPS recognition.
Int J Med Microbiol. 2007 Sep;297(5):353-63. doi: 10.1016/j.ijmm.2007.04.001. Epub 2007 May 3.
6
Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1.
J Exp Med. 2007 Apr 16;204(4):705-14. doi: 10.1084/jem.20062411. Epub 2007 Mar 26.
7
CD4+ T cell-dependent reduction in hepatitis C virus-specific humoral immune responses after HIV infection.
J Infect Dis. 2007 Mar 15;195(6):857-63. doi: 10.1086/511826. Epub 2007 Feb 7.
8
Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.
AIDS. 2006 Nov 28;20(18):2361-9. doi: 10.1097/QAD.0b013e32801086da.
9
Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
Nat Med. 2006 Dec;12(12):1365-71. doi: 10.1038/nm1511. Epub 2006 Nov 19.
10
Abnormal intestinal permeability in primary biliary cirrhosis.
Dig Dis Sci. 2006 Sep;51(9):1607-13. doi: 10.1007/s10620-006-9544-z. Epub 2006 Aug 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验